Comparative analysis of hysterectomy types and approaches on oncological survival in 2023 FIGO stage II endometrial carcinoma
In comparison to SH, RH/mRH did not confer a survival advantage for patients diagnosed with 2023 FIGO stage II EC.
Authors
- Xia Ji (ORCID: https://orcid.org/0000-0001-7597-2769)
- Qing Liu (ORCID: https://orcid.org/0000-0002-6163-2488)
- Jie Huang (ORCID: https://orcid.org/0000-0003-3842-6181)
- Jiayu Chen (ORCID: https://orcid.org/0000-0002-1217-5014)
- Zhenzhen Wu (ORCID: https://orcid.org/0000-0001-6751-6448)
- Yaqin Zhao (ORCID: https://orcid.org/0000-0003-2464-9990)
- Dan Lu (ORCID: https://orcid.org/0000-0003-2672-5053)
- Xiaoli Zhao (ORCID: https://orcid.org/0009-0005-1916-9871)
- Juan Li (ORCID: https://orcid.org/0000-0003-0078-4581)
- Jianhao Sun
- Xinjuan Jiao
- Qinglei Hang
Institutions
- Gansu University of Traditional Chinese Medicine (CN)
- Gansu Provincial Maternal and Child Health Hospital (CN)
- Northern Jiangsu People's Hospital (CN)
- Yangzhou University (CN)
Publication Details
- Journal
- BMC Surgery
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1186/s12893-025-02937-2
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Gansu Province